Immunofluorescence analysis of DNA damage response protein p53-binding protein 1 in a case of uterine dedifferentiated leiomyosarcoma arising from leiomyoma

Pathol Res Pract. 2019 Nov;215(11):152640. doi: 10.1016/j.prp.2019.152640. Epub 2019 Sep 16.

Abstract

Aims: Genomic instability has been indicated during the dedifferentiation process from leiomyoma (LM) to leiomyosarcoma (LMS). Previously, we have described that nuclear expression pattern of DNA damage response protein p53-binding protein 1 (53BP1), detected by immunofluorescence, reflects the magnitude of genomic instability during malignancy. Here, we present a case of LMS arising from LM with molecular analysis of 53BP1, which showed transitional magnitude of DNA damage response within a tumor.

Methods and results: A fifty-year-old female with abdominal mass underwent hysterectomy. Histologically, the tumor consisted of LMS with highly atypical multinucleated giant cells as well as an LM component with transitional atypical spindle cells in the border area. LMS showed diffuse nuclear staining of 53BP1 expression, which has been previously described as high DNA damage response pattern. In contrast, the LM component lacked 53BP1 immunoreactivity and focal expression was observed in transitional lesion. Furthermore, double-labelled immunofluorescence revealed co-localization of 53BP1 with p53 and Ki-67 in the LMS component, which indicated abnormal DNA damage response in proliferative state.

Conclusions: This study revealed that diffuse-type 53BP1 expression may be beneficial to estimate genomic instability during dedifferentiation from LM to DLMS.

Keywords: DNA damage response; Dedifferentiated leiomyosarcoma; Genomic instability; p53-binding protein 1.

Publication types

  • Case Reports

MeSH terms

  • Cell Dedifferentiation / genetics
  • Cell Transformation, Neoplastic / genetics
  • Female
  • Fluorescent Antibody Technique
  • Genomic Instability / genetics
  • Humans
  • Leiomyoma / pathology*
  • Leiomyosarcoma / genetics
  • Leiomyosarcoma / pathology*
  • Middle Aged
  • Neoplasms, Multiple Primary / genetics
  • Neoplasms, Multiple Primary / pathology*
  • Tumor Suppressor p53-Binding Protein 1 / analysis*
  • Uterine Neoplasms / genetics
  • Uterine Neoplasms / pathology*

Substances

  • TP53BP1 protein, human
  • Tumor Suppressor p53-Binding Protein 1